137 related articles for article (PubMed ID: 38269055)
21. A Clinically Translatable Ternary Platinum(IV) Prodrug for Synergistically Reversing Drug Resistance .
Liu Y; Wang D; Liu H; Liu L; Li S; Zhou Z; Lu L; Liu X; He L; He D; Yu CY; Wei H
J Med Chem; 2023 Mar; 66(6):4045-4058. PubMed ID: 36897884
[TBL] [Abstract][Full Text] [Related]
22. Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance.
Hu W; Fang L; Hua W; Gou S
J Inorg Biochem; 2017 Oct; 175():47-57. PubMed ID: 28700961
[TBL] [Abstract][Full Text] [Related]
23. A Dual Stimuli-Responsive Nanoplatform Loaded Pt
Fang K; Sun Y; Yang J; Hu X; Chen M; Li R; Yang X; Fan T; Wu J; Tong X; Dong C; Shi S
Adv Healthc Mater; 2023 Nov; 12(28):e2301328. PubMed ID: 37392128
[TBL] [Abstract][Full Text] [Related]
24. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
25. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
[TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
27. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
[TBL] [Abstract][Full Text] [Related]
28. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
29. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
30. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
[TBL] [Abstract][Full Text] [Related]
31. Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment.
Li Z; Qiao X; Liu XM; Shi SH; Qiao X; Xu JY
Eur J Med Chem; 2023 Mar; 250():115233. PubMed ID: 36863224
[TBL] [Abstract][Full Text] [Related]
32. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug.
Krasnovskaya OO; Akasov RA; Spector DV; Pavlov KG; Bubley AA; Kuzmin VA; Kostyukov AA; Khaydukov EV; Lopatukhina EV; Semkina AS; Vlasova KY; Sypalov SA; Erofeev AS; Gorelkin PV; Vaneev AN; Nikitina VN; Skvortsov DA; Ipatova DA; Mazur DM; Zyk NV; Sakharov DA; Majouga AG; Beloglazkina EK
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12882-12894. PubMed ID: 36854172
[TBL] [Abstract][Full Text] [Related]
33. DNA Nanostructures as Pt(IV) Prodrug Delivery Systems to Combat Chemoresistance.
Zhong YF; Cheng J; Liu Y; Luo T; Wang Y; Jiang K; Mo F; Song J
Small; 2020 Sep; 16(38):e2003646. PubMed ID: 32815274
[TBL] [Abstract][Full Text] [Related]
34. Cancer cell membrane fused liposomal platinum(IV) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy.
Zhang S; Jiang W; Wang S; Song K; Ge M; Zhang L; Yan X; Jiang B
J Mater Chem B; 2023 Dec; 11(47):11384-11393. PubMed ID: 38014915
[TBL] [Abstract][Full Text] [Related]
35. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
[TBL] [Abstract][Full Text] [Related]
36. Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer.
Baz J; Khoury A; Elias MG; Mansour N; Mehanna S; Hammoud O; Gordon CP; Taleb RI; Aldrich-Wright JR; Daher CF
Chem Biol Interact; 2024 Jan; 388():110834. PubMed ID: 38103879
[TBL] [Abstract][Full Text] [Related]
37. β-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype.
Wu WJ; Zhang Y; Zeng ZL; Li XB; Hu KS; Luo HY; Yang J; Huang P; Xu RH
Biochem Pharmacol; 2013 Feb; 85(4):486-96. PubMed ID: 23219523
[TBL] [Abstract][Full Text] [Related]
38. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
39. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
[TBL] [Abstract][Full Text] [Related]
40. Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH.
Chang T; Lian Z; Ma S; Liang Z; Ma X; Wen X; Wang Y; Liu R
Prostate; 2023 Apr; 83(5):470-486. PubMed ID: 36576015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
